See also this year's filing and all EDGAR filings for this company.
PDF Report 0000912183_2012_Cubist_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000912183, Cubist Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,043,274,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 297,113,000 |
| 2 | PropertyPlantAndEquipmentNet | 168,425,000 |
| 3 | remainder_Assets | 378,643,000 |
| 4 | LiabilitiesCurrent | 252,385,000 |
| 5 | LiabilitiesNoncurrent | 30,039,000 |
| 6 | remainder_Liabilities | 805,174,000 |
| 7 | CostOfGoodsAndServicesSold | 172,864,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 163,228,000 |
| 9 | ResearchAndDevelopmentExpense | 184,533,000 |
| 10 | remainder_Expenses | 172,582,000 |
| 11 | remainder_Revenues | 753,972,000 |
| 12 | remainder_NetIncome | -27,742,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,887,455,000 |
| 1 | Liabilities | 1,087,598,000 |
| 2 | Expenses | 693,207,000 |
| 3 | Revenues | 753,972,000 |
| 4 | StockholdersEquity | 799,857,000 |
| 5 | NetIncome | 33,023,000 |
| 6 | ComprehensiveNetIncome | 33,023,000 |
| 7 | BaseVar | 2,224,987,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.19 |
| 9 | EconomicCapitalRatio | 2.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
